GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Days Payable

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Days Payable : 0.00 (As of Dec. 2022)


View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Days Payable?

CERo Therapeutics Holdings's average Accounts Payable for the six months ended in Dec. 2022 was $0.43 Mil. CERo Therapeutics Holdings's Cost of Goods Sold for the six months ended in Dec. 2022 was $0.00 Mil.

The historical rank and industry rank for CERo Therapeutics Holdings's Days Payable or its related term are showing as below:

CERO's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 150.695
* Ranked among companies with meaningful Days Payable only.

CERo Therapeutics Holdings's Days Payable stayed the same from . 20 (0.00) to Dec. 2022 (0.00).

CERo Therapeutics Holdings Days Payable Historical Data

The historical data trend for CERo Therapeutics Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Days Payable Chart

CERo Therapeutics Holdings Annual Data
Trend Dec21 Dec22
Days Payable
- -

CERo Therapeutics Holdings Semi-Annual Data
Dec21 Dec22
Days Payable - -

Competitive Comparison of CERo Therapeutics Holdings's Days Payable

For the Biotechnology subindustry, CERo Therapeutics Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CERo Therapeutics Holdings's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CERo Therapeutics Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where CERo Therapeutics Holdings's Days Payable falls into.


CERo Therapeutics Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

CERo Therapeutics Holdings's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

Days Payable (A: Dec. 2022 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2021 ) + Accounts Payable (A: Dec. 2022 )) / count ) / Cost of Goods Sold (A: Dec. 2022 )*Days in Period
=( (0.46 + 0.391) / 2 ) / 0*365
=0.4255 / 0*365
=N/A

CERo Therapeutics Holdings's Days Payable for the quarter that ended in Dec. 2022 is calculated as:

Days Payable (Q: Dec. 2022 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2021 ) + Accounts Payable (Q: Dec. 2022 )) / count ) / Cost of Goods Sold (Q: Dec. 2022 )*Days in Period
=( (0.46 + 0.391) / 2 ) / 0*365 / 2
=0.4255 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CERo Therapeutics Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Days Payable
Comparable Companies
Traded in Other Exchanges
N/A
Address
201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080
Website
https://www.cero.bio
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines

From GuruFocus

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

By Business Wire • 03-07-2024